US 11110108
Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors
granted A61KA61K31/506A61K31/704
Quick answer
US patent 11110108 (Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61K, A61K31/506, A61K31/704, A61K31/7048, A61K45/06